IFP Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

IFP Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-500	Closed	-$6K	–	4360
2017 Q3	$6K	Hold	500	–	–	﹤0.01%	3356
2017 Q2	$6K	Hold	500	–	–	﹤0.01%	3357
2017 Q1	$5K	Hold	500	–	–	﹤0.01%	3366
2016 Q4	$5K	Hold	500	–	–	﹤0.01%	3359
2016 Q3	$5K	Hold	500	–	–	﹤0.01%	3288
2016 Q2	$7K	Buy	+500	New	+$6.55K	﹤0.01%	2987
2016 Q1	–	Sell	-500	Closed	-$5K	–	4021
2015 Q4	$5K	Buy	+500	New	+$4.18K	﹤0.01%	3018

IFP Advisors's SCLN Position: Q4 2017 in Review

IFP Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 500 shares — an estimated $6K sold.

IFP Advisors first reported a position in SCLN in Q4 2015 and held it in 7 quarters. The position peaked at $7K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

IFP Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
IFP Advisors sold 500 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $6K.
IFP Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q4 2015 and held it in 7 quarters.
IFP Advisors's Sciclone Pharmaceuticals Inc position peaked at $7K in Q2 2016.
0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.